US$ 21.37
glp-1 agonist clinical trials Receptor Agonists as Treatments for Type 2 Diabetes Sometimes innovation comes before the
Description
As more people use these drugs, they're raising big questions about health, who we are, and the future of food-based businesses
Yoshida Y, Joshi P, Barri S, Wang J, Corder AL, OConnell SS, et al

Methodology: BJ

G.BuenoB
This may trigger irregular heartbeats, forcing the heart to work harder than usual, which can be life-threatening
